• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TAEWOONG MEDICAL CO.,LTD. NITI-S PYLORIC & DUODENAL COVERED STENT; PYLORIC & DUODENAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TAEWOONG MEDICAL CO.,LTD. NITI-S PYLORIC & DUODENAL COVERED STENT; PYLORIC & DUODENAL STENT Back to Search Results
Model Number DCT2012BP
Device Problems Break (1069); Fracture (1260); Migration (4003)
Patient Problem Nausea (1970)
Event Date 06/06/2023
Event Type  Injury  
Manufacturer Narrative
It was reported that after 3 months of stent placement, the stent was migrated, and was collapsed during removal.It was confirmed from the device history record that device had been manufactured with no significant issue and passed all the inspections successfully.Migration can occur in any company's device as well as ours.It is affected by patient's lesion status, peristalsis of organs, and drug use in general.In addition, fracture can occur in other company's device as well as ours.It is affected by patient's lesion status, peristalsis of organs, and drug use in general.Duodenum structure where stent was implanted is curvy.Stent can be frequently pressured due to patient's lesion status, and fracture be possible.It is difficult to identify the exact root cause because the device was not returned, and it is difficult to reconstruct the situation at the time of procedure.However, based on the description "migrated part of stent moved much more to the anal side than it used to be on 2023/5/18.The physician tried to remove the stent in the small intestine by forceps through the scope, but the stent collapsed where was held by the forceps.", it is assumed the stent was migrated due to severe pressure at the patient's lesion, peristalsis of organs, foreign substances such as food and other factors complexly.It is assumed this caused the patient to have nausea.Then it is assumed that the migrated stent was fractured due to the combination of continuous stress on the stent from the pressure generated from the patient's lesion, excessive tensile force applied to the stent during removal, and other factors complexly and the fractured part of the stent was removed.Through the user manual by taewoong, it is stated that "potential complications associated with the use of niti-s & comvi stent may include, but are not limited to: stent migration, stent fracture".This suspected device is not registered in the us but we will continuously monitor the same or similar customer complaints through accurate analyses.
 
Event Description
(b)(6) 2021: another stent was placed in the third part of duodenum for pancreatic cancer.(b)(6) 2023 : dct2012bp was placed for the in-growth of stent above.(b)(6) 2023: it was found that a half of dct2012bp was migrated into the small intestine during the periodic inspection.The patient did not have any symptom at that time, so it was determined to monitor without any treatment.(b)(6) 2023 the patient complained of nausea, so the patient investigation was done and revealed that the migrated part of stent moved much more to the anal side than it used to be on (b)(6) 2023.The physician tried to remove the stent in the small intestine by forceps through the scope, but the stent collapsed where was held by the forceps.The stent was finally removed from the small intestine but another half of dct2012bp is remaining in the uncovered stent.No additional treatment is planned, but if it is done later, it would be surgical bypass.The patient is receiving chemotherapy.There is no other complication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NITI-S PYLORIC & DUODENAL COVERED STENT
Type of Device
PYLORIC & DUODENAL STENT
Manufacturer (Section D)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, 10022
KS  10022
Manufacturer (Section G)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, 10022
KS   10022
Manufacturer Contact
lee
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
MDR Report Key17264371
MDR Text Key318545292
Report Number3003902943-2023-00019
Device Sequence Number1
Product Code MUM
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDCT2012BP
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/12/2023
Initial Date FDA Received07/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-